Virpax Pharmaceuticals Inc (VRPX) — Financial Flexibility Index
Virpax Pharmaceuticals Inc (VRPX) has a Financial Flexibility Index of -1.16x as of December 2024. Free cash flow of $-2.87 Million (operating CF $-2.87 Million minus capex $0.00) represents -1% of total liabilities ($2.47 Million). Check VRPX goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Virpax Pharmaceuticals Inc Financial Flexibility Index (2018–2024)
Historical Financial Flexibility Index trend for Virpax Pharmaceuticals Inc across 7 annual periods. For the full cash flow conversion analysis, see VRPX cash flow conversion.
Annual Financial Flexibility Index for Virpax Pharmaceuticals Inc (2018–2024)
Year-by-year free cash flow to debt coverage for Virpax Pharmaceuticals Inc. Explore VRPX cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -6.77x | $-16.71 Billion | $-16.71 Billion | $2.47 Billion | ▼ -428.5% |
| 2023 | -1.28x | $-9.85 Million | $-9.85 Million | $7.69 Million | ▲ +77.8% |
| 2022 | -5.77x | $-17.85 Million | $-17.85 Million | $3.09 Million | ▲ +17.2% |
| 2021 | -6.97x | $-14.54 Million | $-14.54 Million | $2.09 Million | ▼ -2254.8% |
| 2020 | -0.30x | $-1.38 Million | $-1.38 Million | $4.68 Million | ▲ +27.4% |
| 2019 | -0.41x | $-1.13 Million | $-1.13 Million | $2.78 Million | ▲ +71.6% |
| 2018 | -1.43x | $-1.80 Million | $-1.80 Million | $1.25 Million | — |